幸存者诱导的异常症有助于囊性脏和动脉瘤的形成

Wissam A Aboualaiwi¹, Brian S Muntean, Shobha Ratnam+10

• ¹Department of Pharmacology (W.A.A., S.M.N.), Department of Medicinal and Biological Chemistry (B.S.M., S.M.N.), Department of Medicine (S.R., S.M.N.), Center for Hypertension and Personalized Medicine (B.J., S.M.N.), Department of Biochemistry and Cancer Biology (L.L.), and Department of Pathology (R.L.B.), University of Toledo, Toledo, OH; Department of Emergency and Intensive Care, ProMedica Sponsored Research, Toledo, OH (I.R.); Departments of Medicine (B.S.H.) and Medical and Molecular Genetics (R.L.B.), Indiana University School of Medicine, Indianapolis; UCL Institute of Ophthalmology, University College London, London, UK (M.F.); Ontario Cancer Institute, University Health Network, Toronto, ON, Canada (T.W.M.); and Department of Medicine, Brigham and Women's Hospital, Boston, MA (J.Z.).